Cytokine	NN
gene	NN
polymorphisms	NNS
and	CC
serum	NN
cytokine	NN
levels	NNS
in	IN
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
.	.

BACKGROUND	NN
:	:
Studies	NNS
have	VBP
demonstrated	VBN
associations	NNS
between	IN
cytokine	NN
gene	NN
polymorphisms	NNS
and	CC
the	DT
risk	NN
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
.	.

We	PRP
therefore	RB
examined	VBD
polymorphisms	NNS
in	IN
the	DT
genes	NNS
encoding	VBG
interleukin	NN
(	(
IL	NN
)	)
-6	CD
,	,
IL-10	NN
,	,
interferon	NN
gamma	NN
(	(
IFN-y	NN
)	)
,	,
tumor-necrosis-factor-alpha	NN
(	(
TNF-a	NN
)	)
,	,
and	CC
transforming-growth-factor-beta-1	NN
(	(
TGF-b1	NN
)	)
,	,
and	CC
compared	VBD
the	DT
serum	NN
levels	NNS
of	IN
these	DT
cytokines	NNS
in	IN
IPF	NN
patients	NNS
and	CC
healthy	JJ
controls	NNS
.	.

Furthermore	RB
,	,
we	PRP
examined	VBD
the	DT
association	NN
of	IN
the	DT
studied	VBN
genotypes	NNS
and	CC
serum	NN
cytokine	NN
levels	NNS
with	IN
physiological	JJ
parameters	NNS
and	CC
the	DT
extent	NN
of	IN
parenchymal	JJ
involvement	NN
determined	VBN
by	IN
high-resolution	JJ
computed	VBN
tomography	NN
(	(
HRCT	NN
)	)
.	.

METHODS	NNS
:	:
Sixty	CD
patients	NNS
with	IN
IPF	NN
and	CC
150	CD
healthy	JJ
controls	NNS
were	VBD
included	VBN
.	.

Cytokine	NN
genotyping	NN
was	VBD
performed	VBN
using	VBG
the	DT
polymerase	NN
chain	NN
reaction	NN
sequence	NN
specific	JJ
primer	NN
(	(
PCR-SSP	NN
)	)
method	NN
.	.

In	IN
a	DT
subset	NN
of	IN
patients	NNS
and	CC
controls	NNS
,	,
serum	NN
cytokine	NN
levels	NNS
were	VBD
determined	VBN
by	IN
enzyme-linked	JJ
immunosorbent	JJ
assay	NN
.	.

RESULTS	NNS
:	:
There	EX
was	VBD
no	DT
difference	NN
between	IN
IPF	NN
patients	NNS
and	CC
controls	NNS
in	IN
the	DT
genotype	NN
and	CC
allele	NN
distributions	NNS
of	IN
polymorphisms	NNS
in	IN
TNF-a	NN
,	,
IFN-y	NN
,	,
IL-6	NN
,	,
IL-10	NN
,	,
and	CC
TGF-b1	NN
(	(
all	DT
p	NN
>	JJR
0.05	CD
)	)
.	.

The	DT
TNF-a	NN
(	(
-308	CD
)	)
GG	NNS
,	,
IL-6	NN
(	(
-174	CD
)	)
GG	NNS
and	CC
CG	NN
,	,
and	CC
IL-10	NN
(	(
-1082	CD
,	,
-819	CD
,	,
-592	CD
)	)
ACC	NNP
ATA	NN
genotypes	NNS
were	VBD
significantly	RB
associated	VBN
with	IN
HRCT	NN
scores	NNS
(	(
all	DT
p	NN
<	JJR
0.05	CD
)	)
.	.

IL-10	NN
(	(
-1082	CD
,	,
-819	CD
,	,
-592	CD
)	)
ACC	NN
haplotype	NN
was	VBD
associated	VBN
with	IN
the	DT
diffusion	NN
capacity	NN
of	IN
the	DT
lung	NN
for	IN
carbon	NN
monoxide	NN
,	,
and	CC
ATA	NN
haplotype	NN
was	VBD
associated	VBN
with	IN
the	DT
partial	JJ
pressure	NN
of	IN
oxygen	NN
(	(
PaO2	NN
)	)
(	(
all	DT
p	NN
<	JJR
0.05	CD
)	)
.	.

The	DT
TGF-b1	NN
(	(
codons	NNS
10	CD
and	CC
25	CD
)	)
TC	NN
GG	NNS
,	,
TC	NN
GC	NN
,	,
CC	NN
GG	NNS
and	CC
CC	NN
GC	NN
genotypes	NNS
were	VBD
significantly	RB
associated	VBN
with	IN
the	DT
PaO2	NN
and	CC
HRCT	NN
scores	NNS
(	(
p	NN
<	JJR
0.05	CD
)	)
.	.

The	DT
TGF-b1	NN
(	(
codons	NNS
10	CD
and	CC
25	CD
)	)
CC	NN
GG	NNS
genotype	NN
(	(
5	CD
patients	NNS
)	)
was	VBD
significantly	RB
associated	VBN
with	IN
higher	JJR
PaO2	NN
value	NN
and	CC
less	JJR
parenchymal	JJ
involvement	NN
(	(
i.e.	FW
,	,
a	DT
lower	JJR
total	JJ
extent	NN
score	NN
)	)
compared	VBN
to	TO
the	DT
other	JJ
TGF-b1	NN
genotypes	NNS
(	(
81.5	CD
11.8	CD
mm	NN
Hg	NN
vs.	CC
67.4	CD
11.1	CD
mm	NN
Hg	NN
,	,
p	NN
=	JJ
0.009	CD
and	CC
5.60	CD
1.3	CD
vs.	IN
8.51	CD
2.9	CD
,	,
p	NN
=	JJ
0.037	CD
,	,
respectively	RB
)	)
.	.

Significant	JJ
differences	NNS
were	VBD
noted	VBN
between	IN
patients	NNS
(	(
n	NN
=	JJ
38	CD
)	)
and	CC
controls	NNS
(	(
n	NN
=	JJ
36	CD
)	)
in	IN
the	DT
serum	NN
levels	NNS
of	IN
IL-6	NN
and	CC
IL-10	NN
(	(
both	CC
,	,
p	NN
<	JJR
0.0001	CD
)	)
,	,
but	CC
not	RB
in	IN
the	DT
levels	NNS
of	IN
TNF-a	NN
and	CC
TGF-b1	NN
(	(
both	CC
,	,
p	NN
>	JJR
0.05	CD
)	)
.	.

CONCLUSION	NN
:	:
The	DT
studied	VBN
genotypes	NNS
and	CC
alleles	NNS
do	VBP
not	RB
predispose	VB
to	TO
the	DT
development	NN
of	IN
IPF	NN
but	CC
appear	VBP
to	TO
play	VB
an	DT
important	JJ
role	NN
in	IN
disease	NN
severity	NN
.	.

Our	PRP$
results	NNS
suggest	VBP
that	IN
the	DT
TGF-b1	NN
(	(
codons	NNS
10	CD
and	CC
25	CD
)	)
CC	NN
GG	NNS
genotype	NN
could	MD
be	VB
a	DT
useful	JJ
genetic	JJ
marker	NN
for	IN
identifying	VBG
a	DT
subset	NN
of	IN
IPF	NN
patients	NNS
with	IN
a	DT
favorable	JJ
prognosis	NN
;	:
however	RB
,	,
validation	NN
in	IN
a	DT
larger	JJR
sample	NN
is	VBZ
required	VBN
.	.

